Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guozhen Tan

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|June 6, 2013
Hydrogen sulfide inhibits abnormal proliferation of lymphocytes via AKT/GSK3β signal pathway in systemic lupus erythematosus patientsYanfang Han, Fanqin Zeng, Guozhen Tan, et al.
Advances in Rheumatology (London, England)|December 10, 2022
CD19<sup>+</sup>CD24<sup>high</sup>CD27<sup>+</sup> B cell and interleukin 35 as potential biomarkers of disease activity in systemic lupus erythematosus patientsHui Xiong, Zengqi Tang, Ying Xu, et al.
Psoriasis (Auckland, N.Z.)|April 1, 2026
Indole-3-Lactic Acid Attenuates IMQ-Induced Psoriasiform Dermatitis in Mice via AhR-Dependent Suppression of IL-17AZhen Meng, Jieru Ren, Yuhsien Lai, et al.
International Immunopharmacology|April 12, 2024
Decreased HMGCS1 inhibits proliferation and inflammatory response of keratinocytes and ameliorates imiquimod-induced psoriasis via the STAT3/IL-23 axisLin Chen, Danqi Huang, Zhongzhou Huang, et al.
Frontiers in Immunology|August 23, 2021
ULK1 Inhibition as a Targeted Therapeutic Strategy for Psoriasis by Regulating Keratinocytes and Their Crosstalk With NeutrophilsXiaonan Qiu, Lin Zheng, Xiuting Liu, et al.
International Immunopharmacology|September 4, 2022
Anti-galectin-3 antibodies induce skin vascular inflammation via promoting local production of IL-1β in systemic lupus erythematosusZhenrui Shi, Yu-Ping Zhang, Dan Hong, et al.
The Journal of Investigative Dermatology|August 28, 2025
Metformin treatment protects mice from glucose-promoted psoriasiform dermatitis through enrichment of Akkermansia muciniphila with modulation of bacterial tryptophan metabolitesYuhsien Lai, Zhuoyu Jiang, Xiaonan Qiu, et al.
Bioactive Materials|August 6, 2024
Topical treatment of tyrosine kinase 2 inhibitor through borneol-embedded hydrogel: Evaluation for preventive, therapeutic, and Recurrent management of psoriasisYuhsien Lai, Xuesong Wu, Zhuoyu Jiang, et al.
Ebiomedicine|March 9, 2023
Cytotoxic CD161<sup>-</sup>CD8<sup>+</sup> T<sub>EMRA</sub> cells contribute to the pathogenesis of systemic lupus erythematosusHui Xiong, Mintian Cui, Ni Kong, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|June 6, 2013
Hydrogen sulfide inhibits abnormal proliferation of lymphocytes via AKT/GSK3β signal pathway in systemic lupus erythematosus patientsYanfang Han, Fanqin Zeng, Guozhen Tan, et al.
Advances in Rheumatology (London, England)|December 10, 2022
CD19<sup>+</sup>CD24<sup>high</sup>CD27<sup>+</sup> B cell and interleukin 35 as potential biomarkers of disease activity in systemic lupus erythematosus patientsHui Xiong, Zengqi Tang, Ying Xu, et al.
Psoriasis (Auckland, N.Z.)|April 1, 2026
Indole-3-Lactic Acid Attenuates IMQ-Induced Psoriasiform Dermatitis in Mice via AhR-Dependent Suppression of IL-17AZhen Meng, Jieru Ren, Yuhsien Lai, et al.
International Immunopharmacology|April 12, 2024
Decreased HMGCS1 inhibits proliferation and inflammatory response of keratinocytes and ameliorates imiquimod-induced psoriasis via the STAT3/IL-23 axisLin Chen, Danqi Huang, Zhongzhou Huang, et al.
Frontiers in Immunology|August 23, 2021
ULK1 Inhibition as a Targeted Therapeutic Strategy for Psoriasis by Regulating Keratinocytes and Their Crosstalk With NeutrophilsXiaonan Qiu, Lin Zheng, Xiuting Liu, et al.
International Immunopharmacology|September 4, 2022
Anti-galectin-3 antibodies induce skin vascular inflammation via promoting local production of IL-1β in systemic lupus erythematosusZhenrui Shi, Yu-Ping Zhang, Dan Hong, et al.
The Journal of Investigative Dermatology|August 28, 2025
Metformin treatment protects mice from glucose-promoted psoriasiform dermatitis through enrichment of Akkermansia muciniphila with modulation of bacterial tryptophan metabolitesYuhsien Lai, Zhuoyu Jiang, Xiaonan Qiu, et al.
Bioactive Materials|August 6, 2024
Topical treatment of tyrosine kinase 2 inhibitor through borneol-embedded hydrogel: Evaluation for preventive, therapeutic, and Recurrent management of psoriasisYuhsien Lai, Xuesong Wu, Zhuoyu Jiang, et al.
Ebiomedicine|March 9, 2023
Cytotoxic CD161<sup>-</sup>CD8<sup>+</sup> T<sub>EMRA</sub> cells contribute to the pathogenesis of systemic lupus erythematosusHui Xiong, Mintian Cui, Ni Kong, et al.
Pageof 3